Company News
-
The Hygienic Home Test: Early Detection for Colorectal Cancer and Peace of Mind
What is Fecal Occult Blood? Fecal occult blood refers to minute quantities of blood present in stool that are invisible to the naked eye. Although undetectable without specific testing, its presence can indicate a variety of gastrointestinal conditions. Diseases Associated with Fecal Occult Blo...Read more -
Cervical Cancer Awareness 2026: Understanding the Timeline and Taking Action with Advanced Tools
January 2026 marks Cervical Cancer Awareness Month, a pivotal moment in the World Health Organization’s (WHO) global strategy to eliminate cervical cancer by 2030. Understanding the progression from an HPV infection to cervical cancer is crucial in empowering people to contribute to this gl...Read more -
When 72 Hours Is Too Late: Why Rapid MRSA Detection Saves Lives
Traditional Culture Takes Too Long — Patients Cannot Wait In clinical practice, bacterial culture and antimicrobial susceptibility testing typically require 48–72 hours to deliver results.For critically ill patients, however, those 72 hours can mean the difference between life and death. What o...Read more -
Understanding the Global AMR Threat: 1.27 Million Lives Lost in 2019
A recent landmark study published in The Lancet revealed a sobering reality: 1.27 million deaths in 2019 were directly attributable to antimicrobial resistance (AMR). Even more alarming, 73% of these deaths were caused by just six pathogens: 1.Escherichia coli 2.Staphylococcus aureus 3.Klebsiell...Read more -
AIO 800+ STI-14: A Flagship Solution for Modern STI Control
Why Macro & Micro-Test’s AIO 800 Sample-to-Answer Protocol Matters for STI Control Sexually transmitted infections (STIs) continue to pose a major global public health challenge, driven largely by delayed diagnosis and widespread asymptomatic transmission. To address these gaps, Macro &...Read more -
How Can Freeze-Drying Technology Make Molecular Diagnostics More Stable, Cost-Effective, Simple, and Convenient? Macro & Micro-Test(MMT) Has the Innovative Answer!
As nucleic acid testing becomes a routine necessity, have you faced these challenges: reagents that risk degradation during transport, contamination-prone opening procedures, or activity loss from repeated freeze-thaw cycles? A century-old “age-defying” technology—vacuum freeze-drying...Read more -
From Vague Threat to Clear Action: Redefining the Standard with HPV 28 Genotyping
Human papillomavirus (HPV) infections are extremely common. While the majority of infections are cleared by the immune system within 1-2 years without consequence, a small percentage of persistent high-risk HPV infections can silently initiate a carcinogenic process that may span 10 to 20 years. ...Read more -
Fully Automation Molecular POCT and NGS For Diarrhea Detection
Diarrhea is often a sign of gastrointestinal infection caused by viruses, bacteria, or other pathogens. It poses significant risks not only to children but also to the elderly, immunocompromised individuals, and people in crowded or post-disaster settings. Particularly during the autumn and winte...Read more -
Transforming C. diff Detection: Achieving Fully Automated, Sample-to-Answer Molecular Diagnostics
What causes C. Diff infection? Diff infection is caused by a bacterium known as Clostridioides difficile (C. difficile), that usually resides harmlessly in the intestines. However, when the gut’s bacterial balance is disturbed, often broad-spectrum antibiotic use, C. difficile can grow excessive...Read more -
Beyond the Common Cold: Understanding the True Impact of Human Metapneumovirus (hMPV)
When a child develops a runny nose, cough, or fever, many parents instinctively think of the common cold or flu. Yet a significant share of these respiratory illnesses—especially the more severe ones—are caused by a lesser-known pathogen: Human Metapneumovirus (hMPV). Since its discovery in 2001,...Read more -
From Silent Infection to Preventable Tragedy: Break the Chain with Sample-to-Answer HR-HPV Screening
This moment matters. Every life counts. Under the global call to “Act Now: Eliminate Cervical Cancer,” the world is accelerating toward the 90-70-90 targets by 2030: -90% of girls vaccinated against HPV by age 15 -70% of women screened with a high-performance test by ages 35 and 45 -90% of women ...Read more -
The Silent Pandemic Amplifying TB’s Threat: AMR Crisis Looms
The #WHO’s latest tuberculosis report reveals a stark reality: 8.2 million new TB cases were diagnosed in 2023—the highest since global monitoring began in 1995. This surge from 7.5 million in 2022 reinstates TB as the leading infectious disease killer, surpassing COVID-19. Yet, an even graver cr...Read more